Invesco
NUTX

Invesco’s Nutex Health NUTX Stock Holding History

Invesco’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$400K Sell
4,206
-686
-14% -$84.1K ﹤0.01% 3243
2025
Q4 		$805K Buy
4,892
+2,874
+142% +$381K ﹤0.01% 3001
2025
Q3 		$208K Sell
2,018
-52
-3% -$5.1K ﹤0.01% 3554
2025
Q2 		$258K Buy
+2,070
New +$267K ﹤0.01% 3429
2023
Q4 		– Sell
-72
Closed -$2.19K – 3874
2023
Q3 		$2.19K Hold
72
– – ﹤0.01% 3868
2023
Q2 		$4.56K Sell
72
-440
-86% -$37.7K ﹤0.01% 3858
2023
Q1 		$77.6K Buy
512
+14
+3% +$2.83K ﹤0.01% 3724
2022
Q4 		$142K Buy
498
+385
+341% +$73.9K ﹤0.01% 3771
2022
Q3 		$25K Buy
113
+13
+13% +$5.51K ﹤0.01% 3962
2022
Q2 		$48K Buy
+100
New +$118K ﹤0.01% 3971

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Invesco's NUTX Position: Q1 2026 in Review

Invesco reduced its Nutex Health (NUTX) stake by 14% in Q1 2026, selling an estimated $84.1K and leaving 4,206 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #3243.

Invesco first reported a position in NUTX in Q2 2022 and has held it in 10 quarters since. The position peaked at $805K in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Invesco held 4,206 shares of Nutex Health worth $400K as of Q1 2026.
  • Invesco sold 686 Nutex Health shares in Q1 2026, an estimated $84.1K.
  • Nutex Health made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3243 holding.
  • Invesco first reported a position in Nutex Health in Q2 2022 and has held it in 10 quarters since.
  • Invesco's Nutex Health position peaked at $805K in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.